Hitchcock Todd A

SEC source: 0001261654-21-000008 · wf-form4_161057613551220.xml · nonDerivative · entry 2

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,707

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 1/7/2020.

SEC source: 0001261654-21-000008 · wf-form4_161057613551220.xml · nonDerivative · entry 1

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,848

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-20-000083 · wf-form4_160798920766941.xml · derivative · entry 2

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,182

Underlying: Common Stock, $0.0001 par value · 15,637 shares

Expires 2023-12-10

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000083 · wf-form4_160798920766941.xml · derivative · entry 1

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,781

Underlying: Common Stock, $0.0001 par value · 26,134 shares

Expires 2023-12-10

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001209191-20-002755 · doc4.xml · derivative · entry 2

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,647

Underlying: Common Stock · 21,647 shares

Expires 2022-01-07

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2021 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2021, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2021 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2021, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001209191-20-002755 · doc4.xml · nonDerivative · entry 1

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,545

F1 · shares: One third of the restricted stock units approved by the Board of Directors shall vest on each anniversary of the grant date.

SEC source: 0001261654-20-000107 · wf-form4a_160876280886733.xml · derivative · entry 1

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,182

Underlying: Common Stock, $0.0001 par value · 11,545 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F2 · shares: This Form 4/A does not report a new transaction. The reporting person's original Form 4 incorrectly reported these securities as Common Stock rather than restricted stock units.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on January 7, 2021.

F3 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on January 7, 2021.

F4 · balance_after: The incorrect classification described in footnote (2) above resulted in incorrect reporting of beneficial ownership of the UTI Common Stock in the original Form 4. As of the date of this Form 4/A, none of the restricted stock units has vested. The beneficial ownership of the restricted stock units has been corrected in this Form 4/A and reflects the reporting person's correct ownership as of the date of this filing.